Firefly Neuroscience, Inc.
AIFF · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $38,397 | $35,852 | $39,131 | $22,171 |
| - Cash | $4,325 | $5,918 | $9,545 | $1,810 |
| + Debt | $0 | $0 | $0 | $694 |
| Enterprise Value | $34,072 | $29,934 | $29,586 | $21,055 |
| Revenue | $388 | $299 | $43 | $53 |
| % Growth | 29.8% | 595.3% | -18.9% | – |
| Gross Profit | $146 | $274 | $43 | $53 |
| % Margin | 37.6% | 91.6% | 100% | 100% |
| EBITDA | -$2,403 | -$1,771 | -$12,783 | -$2,558 |
| % Margin | -619.3% | -592.3% | -29,727.9% | -4,826.4% |
| Net Income | -$2,639 | -$1,833 | -$12,930 | -$3,785 |
| % Margin | -680.2% | -613% | -30,069.8% | -7,141.5% |
| EPS Diluted | -0.2 | -0.14 | -1.74 | -0.45 |
| % Growth | -42.9% | 92% | -286.7% | – |
| Operating Cash Flow | -$1,488 | -$2,390 | -$2,511 | -$1,218 |
| Capital Expenditures | -$86 | -$12 | -$7 | -$80 |
| Free Cash Flow | -$1,574 | -$2,402 | -$2,518 | -$1,298 |